Reliance Trust’s Bristol-Myers Squibb BMY Stock Holding History

Reliance Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-7,300	Closed	-$431K	–	19
2014 Q4	$431K	Sell	7,300 -1,711	-19%	-$96.5K	0.5%	60
2014 Q3	$461K	Sell	9,011 -74	-0.8%	-$3.7K	0.53%	56
2014 Q2	$441K	Sell	9,085 -1,904	-17%	-$93.8K	0.5%	61
2014 Q1	$571K	Sell	10,989 -91	-0.8%	-$4.84K	0.56%	52
2013 Q4	$589K	Sell	11,080 -308	-3%	-$15.7K	0.56%	53
2013 Q3	$527K	Sell	11,388 -1,633	-13%	-$71.7K	0.51%	55
2013 Q2	$582K	Buy	+13,021	New	+$565K	0.38%	65

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Reliance Trust's BMY Position: Q1 2015 in Review

Reliance Trust sold out of Bristol-Myers Squibb (BMY) in Q1 2015, closing a stake of 7,300 shares — an estimated $431K sold.

Reliance Trust first reported a position in BMY in Q2 2013 and held it in 7 quarters. The position peaked at $589K in Q4 2013. 1,450 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

Reliance Trust reported no remaining Bristol-Myers Squibb position as of Q1 2015 after selling out during the quarter.
Reliance Trust sold 7,300 Bristol-Myers Squibb shares in Q1 2015, an estimated $431K.
Reliance Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 7 quarters.
Reliance Trust's Bristol-Myers Squibb position peaked at $589K in Q4 2013.
1,450 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Reliance Trust's 13F filing for Q1 2015, filed 24 Apr 2015.